Tuesday, November 24, 2015
Exclusive: ValueAct gains for the year wiped out by Valeant loss
(Reuters) - Activist investor ValueAct Capital said its fund fell 8.3 percent during the third quarter, wiping out its gains for the year, hurt by a plunge in shares of its main portfolio company, Valeant Pharmaceuticals International Inc .
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment